Research output per year
Research output per year
Personal profile
Research interests
Clinical trials in breast cancer especially in patients with triple negative disease, early-onset breast cancer, racial disparities.
Clinical interests
Medical Oncology, breast cancer, breast oncology
Fingerprint
Dive into the research topics where Foluso Ademuyiwa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)
Ademuyiwa, F. O., Northfelt, D. W., O’Connor, T., Levine, E., Luo, J., Tao, Y., Hoog, J., Laury, M. L., Summa, T., Hammerschmidt, T., Guo, Z., Frith, A., Weilbaecher, K., Opyrchal, M., Aft, R., Clifton, K., Suresh, R., Bagegni, N., Hagemann, I. S., Iglesia, M. D., & 1 others, Dec 2023, In: npj Breast Cancer. 9, 1, 1.Research output: Contribution to journal › Article › peer-review
Open Access -
Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race
Berrian, J., Liu, Y., Ezenwajiaku, N., Moreno-Aspitia, A., Holton, S. J., Toriola, A. T., Colditz, G., Housten, A. J., Hall, L., Fiala, M. A. & Ademuyiwa, F. O., Mar 2023, In: Cancer medicine. 12, 6, p. 7381-7388 8 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis
Krishnamurthy, J., Luo, J., Suresh, R., Ademuyiwa, F., Rigden, C., Rearden, T., Clifton, K., Weilbaecher, K., Frith, A., Roshal, A., Tandra, P. K., Cherian, M., Summa, T., Haas, B., Thomas, S., Hernandez-Aya, L., Bergqvist, M., Peterson, L. & Ma, C. X., Dec 2022, In: npj Breast Cancer. 8, 1, 35.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013
Ademuyiwa, F. O., Gao, F., Street, C. R., Chen, I., Northfelt, D. W., Wesolowski, R., Arora, M., Brufsky, A., Dees, E. C., Santa-Maria, C. A., Connolly, R. M., Force, J., Moreno-Aspitia, A., Herndon, J. M., Carmody, M., Davies, S. R., Larson, S., Pfaff, K. L., Jones, S. M., Weirather, J. L., & 6 others, Dec 2022, In: npj Breast Cancer. 8, 1, 134.Research output: Contribution to journal › Article › peer-review
Open Access -
Call for action: expanding global access to hereditary cancer genetic testing
Bychkovsky, B., Rana, H. Q., Ademuyiwa, F., Plichta, J., Anderson, K., Nogueira-Rodrigues, A., Santa-Maria, C. A., Coffman, L. G., Marquez, C., Das, A., Taghian, A., Koeller, D. R., Sandoval, R. L., Park, B. H. & Dizon, D. S., Sep 2022, In: The Lancet Oncology. 23, 9, p. 1124-1126 3 p.Research output: Contribution to journal › Comment/debate
2 Scopus citations